kvue good buy?

kvue good buy? AI+
Guy 03-10 US Equity Public

kvue good buy?

Rate this post:
1
Kommentarer (3)
AI+ Standard 03-10
Dette svar blev genereret af AI. Selvom vi stræber efter nøjagtighed, kan det indeholde fejl.

Kenvue Inc. (NYSE: KVUE) operates in the consumer health sector, focusing on over-the-counter medications, beauty, and wellness products, following its spin-off from Johnson & Johnson. The company maintains a substantial market capitalization of approximately $41.12 billion as of August 6, 2025.1

From a quantitative perspective, here's a look at some key indicators:

  • Institutional Ownership: Kenvue is widely held by institutions, with 1,994 institutional owners collectively holding about 2.23 billion shares.2 Major holders include Vanguard Group Inc, BlackRock, Inc., and State Street Corp.2 Recent 13G/A filings show mixed institutional activity; for instance, Vanguard Group Inc. increased its holdings by nearly 10% as of July 29, 2025, while others like Price T Rowe Associates Inc /MD/ and Fmr Llc reduced their positions.2
  • Short Interest: The short interest in KVUE is relatively low, with 36.40 million shares shorted, representing 1.90% of the float.1 The "Days to Cover" stands at 2.47 days, suggesting that short positions could be covered quickly, and the borrow rate is low at 0.40%.1 This indicates limited bearish sentiment from short sellers.
  • Dividend Profile: Kenvue offers a dividend yield of 3.83% as of August 6, 2025, with quarterly payments recently around $0.20-$0.21 per share.1
  • Analyst Sentiment: The average one-year price target for KVUE is $24.19, with a range from $20.20 to $30.45.1 Recent analyst initiations have been "Neutral" or "In-Line," suggesting a consensus for performance in line with the broader market.1
  • Piotroski F-Score: Kenvue holds a Piotroski F-Score of 6.00 out of 9, which generally indicates a sound financial position.1

Overall, Kenvue presents as a stable consumer health company with significant institutional backing and a consistent dividend. The low short interest suggests a lack of aggressive bearish bets against the stock.

Rate this response:
0

Guy 03-10

qqqi a good buy?


AI+ Standard 03-10
Dette svar blev genereret af AI. Selvom vi stræber efter nøjagtighed, kan det indeholde fejl.

NEOS Nasdaq-100 High Income ETF (NasdaqGM: QQQI) is an exchange-traded fund designed to provide income exposure to the Nasdaq-100 index. As an ETF, its investment profile differs from individual equities like Kenvue.

Here's an overview of QQQI's quantitative characteristics:

  • Dividend Profile: QQQI currently boasts a high dividend yield of 15.06% as of August 6, 2025. The fund pays dividends monthly, with recent distributions ranging from $0.53 to $0.64 per share. Its dividend growth rate stands at 1.19%.1
  • Institutional Ownership: QQQI is held by a notable number of institutional investors. Fintel data indicates there are 108 institutional owners, with 107 holding long-only positions. These institutions collectively own 2,841,905 shares (excluding 13D/G filings). Significantly, institutional long shares increased by 58.55% in the most recent quarter. Prominent holders include Second Half Financial Partners, LLC, LPL Financial LLC, and Tyler-Stone Wealth Management.2
  • Short Interest: The short interest in QQQI is relatively low, with 762,988 shares shorted. The "Days to Cover" is very low at 0.26 days, suggesting that short positions could be covered quickly. The borrow rate is also low at 0.47. A notable point is the high off-exchange short volume ratio of 67.02%, indicating a significant portion of shorting activity occurs outside traditional exchanges.3
  • Analyst Coverage and Piotroski Score: As an ETF, QQQI typically does not have individual analyst price targets or a Piotroski F-Score, which are metrics more commonly applied to individual operating companies.

In summary, QQQI presents as an ETF focused on high income, evidenced by its substantial dividend yield and monthly payouts. The significant increase in institutional long positions suggests growing interest from professional money managers. Its low short interest and days to cover indicate limited bearish sentiment.

Rate this response:
0

Tilføj en kommentar eller stil et opfølgende spørgsmål
Fortæl os, hvad du har at sige. Du kan inkludere links, men ikke *bare* links. Del dine tankevækkende meninger. Brug Markdown .
Using Standard
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista